News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Newamsterdam Pharma Successfully Completes Patient Enrollment for Pivotal Phase 3 BROADWAY Clinical Trial Studying Obicetrapib in Individuals
Wednesday, July 26, 2023NewAmsterdam Pharma Company NV Nasdaq NAMS has successfully completed patient enrollment for its pivotal Phase BROADWAY clinical trial
EU Approves Jardiance® (Empagliflozin) for the Treatment of Chronic Kidney Disease in Adults
Wednesday, July 26, 2023Boehringer Ingelheim and Eli Lilly jointly announced today that the European Commission EC has granted approval for Jardiance empagliflozin to be used in the treatment of adults with chronic kidney disease CKD
FDA Approves XVIVO's Inclusion of DCD Hearts in IDE Clinical Trial
Wednesday, July 26, 2023XVIVO Perfusion AB STOXVIVOLSERKLFRAXV has received approval from the US Food Drug Administration FDA to include Donation after Circulatory Death DCD hearts in its heart preservation clinical trial known as the PRESERVE Clinical Trial
Nexus Pharmaceuticals, Inc. Receives FDA Approval for Their Pre-Filled Syringe of EMERPHED® (ephedrine sulfate injection)
Tuesday, July 25, 2023Nexus Pharmaceuticals Inc has recently received approval from the US Food and Drug Administration FDA for its latest product EMERPHED ephedrine sulfate injection which comes in two variants of prefilled syringes mgmL and mgmL
Crescendo Biologics Secures $32 Million in Funding and Announces the Expansion of the CB307 Phase 1b Trial in PSMA+ Solid Tumors
Tuesday, July 25, 2023Crescendo Biologics Ltd Crescendo is a clinical stage immunooncology company focused on developing novel targeted T cell enhancing therapeutics Recently the company announced its plans to enhance the ongoing Phase b clinical trial
Overland ADCT Biopharma's ZYNLONTA® Receives Priority Review From NMPA for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Tuesday, July 25, 2023Overland ADCT BioPharma has made a significant announcement regarding their drug ZYNLONTA loncastuximab tesirinelpyl in China The China National Medical Products Administration NMPA has accepted the Biologics License Application BLA for ZYNLONTA
Molecure's Flagship Program, OATD-01, Granted FDA Approval for Phase Ii Clinical Testing Launch
Tuesday, July 25, 2023Molecure SA a biotechnology company listed on the WSE has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND Application
Eagle Pharmaceuticals Commences Phase 2 Clinical Trial to Evaluate CAL02, a Novel First-in-class Anti-toxin Drug Candidate, for Severe Community-acquired Bacterial Pneumonia (SCABP) Treatment
Monday, July 24, 2023Eagle Pharmaceuticals Inc Nasdaq EGRX has commenced a Phase study for CAL a groundbreaking antivirulence agent in severe communityacquired bacterial pneumonia SCABP patients
Menarini Group's ORSERDU® (Elacestrant) Receives Positive CHMP Opinion for European Commission Approval in Locally Advanced or Metastatic Breast Cancer with ESR1 Activating Mutation
Saturday, July 22, 2023The Menarini Group a renowned international pharmaceutical and diagnostics company along with its subsidiary Stemline Therapeutics Inc has received a positive opinion from the Committee for Medicinal Products for Human Use CHMP of the European Medici...
CHMP Approves Evrysdi® for Infants Under Two Months with Spinal Muscular Atrophy
Saturday, July 22, 2023PTC Therapeutics Inc NASDAQ PTCT has received a positive opinion from the Committee for Medicinal Products for Human Use CHMP for the extension of the Evrysdi risdiplam marketing authorization in the European Union EU to include infants under two mon...
